Colorectal cancer screening: Assessment of CEACAM6, LGALS4, TSPAN8 and COL1A2 as blood markers in faecal immunochemical test negative subjects

Hadjipetrou, 2017, Colorectal cancer, screening and primary care: a mini literature review, World J Gastroenterol, 23, 6049, 10.3748/wjg.v23.i33.6049 Ferlay, 2019, Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods, Int J Cancer, 144, 1941, 10.1002/ijc.31937 Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 68, 394, 10.3322/caac.21492 Senore, 2018, Status of implementation and organization of cancer screening in The European Union Member States—Summary results from the second European screening report, Int J Cancer, 142, 44, 10.1002/ijc.31043 Benson, 2012, Toward standardizing and reporting colorectal cancer screening indicators on an international level: the international colorectal cancer screening network, Int J Cancer, 130, 2961, 10.1002/ijc.26310 Venturelli, 2019, Associations between cervical, breast and colorectal cancer screening uptake, chronic diseases and health-related behaviours: Data from the Italian PASSI nationwide surveillance, Prev Med, 120, 60, 10.1016/j.ypmed.2019.01.007 Zorzi, 2018, Long-term performance of colorectal cancer screening programmes based on the faecal immunochemical test, Gut, 67, 2124, 10.1136/gutjnl-2017-314753 Schreuders, 2015, Colorectal cancer screening: A global overview of existing programmes, Gut, 64, 1637, 10.1136/gutjnl-2014-309086 Idigoras Rubio, 2019, Participation in a population-based screening for colorectal cancer using the faecal immunochemical test decreases mortality in 5 years, Eur J Gastroenterol Hepatol, 31, 197, 10.1097/MEG.0000000000001338 Rosso, 2019, Non-invasive markers to detect colorectal cancer in asymptomatic population, Minerva Biotecnol, 31, 23, 10.23736/S1120-4826.18.02493-X Botteri, 2016, Predictors of advanced colorectal neoplasia at initial and surveillance colonoscopy after positive screening immunochemical faecal occult blood test, Dig Liver Dis, 48, 321, 10.1016/j.dld.2015.11.020 Tao, 2013, Comparative evaluation of nine faecal immunochemical tests for the detection of colorectal cancer, Acta Oncol, 52, 1667, 10.3109/0284186X.2013.789141 Normanno, 2018, The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios, Cancer Treat Rev, 70, 1, 10.1016/j.ctrv.2018.07.007 Rodia, 2016, Systematic large-scale meta-analysis identifies a panel of two mRNAs as blood biomarkers for colorectal cancer detection, Oncotarget, 7, 30295, 10.18632/oncotarget.8108 Gemei, 2013, CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo, Cancer, 119, 729, 10.1002/cncr.27794 Kuroki, 1999, Nonspecific cross-reacting antigen-50/90 (NCA-50/90) as a new tumor marke, Anticancer Res, 19, 5599 Cao, 2016, The role of galectin-4 in physiology and diseases, Protein Cell, 7, 314, 10.1007/s13238-016-0262-9 Makoto, 2011, Clinical significance of circulating galectins as colorectal cancer markers, Oncol Rep, 25, 1217 Richardson, 2011, Tetraspanins and tumor progression, Clin Exp Metastasis, 28, 261, 10.1007/s10585-010-9365-5 Nazarenko, 2010, Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation, Cancer Res, 70, 1668, 10.1158/0008-5472.CAN-09-2470 Greco, 2010, E-cadherin/p120-catenin and tetraspanin Co-029 cooperate for cell motility control in human colon carcinoma, Cancer Res, 70, 7674, 10.1158/0008-5472.CAN-09-4482 Rodia, 2018, LGALS4, CEACAM6, TSPAN8, and COL1A2: blood markers for colorectal cancer—validation in a cohort of subjects with positive fecal immunochemical test result, Clin Colorectal Cancer, 17, e217, 10.1016/j.clcc.2017.12.002 Hamm, 2016, Tumour-educated circulating monocytes are powerful candidate biomarkers for diagnosis and disease follow-up of colorectal cancer, Gut, 65, 990, 10.1136/gutjnl-2014-308988 Broeders, 2014, Guidelines for validation of qualitative real-time PCR methods, Trends Food Sci Technol, 37, 115, 10.1016/j.tifs.2014.03.008 Mattocks, 2010, A standardized framework for the validation and verification of clinical molecular genetic tests, Eur J Hum Genet, 18, 1276, 10.1038/ejhg.2010.101 Ganepola, 2014, Use of blood-based biomarkers for early diagnosis and surveillance of colorectal cancer, World J Gastrointest Oncol, 6, 83, 10.4251/wjgo.v6.i4.83 Yamada, 2019, Liquid biopsy for the management of patients with colorectal cancer, Digestion, 99, 39, 10.1159/000494411 Yörüker, 2016, Blood-based biomarkers for diagnosis, prognosis and treatment of colorectal cancer, Clin Chim Acta, 455, 26, 10.1016/j.cca.2016.01.016 Navarro, 2017, Colorectal cancer population screening programs worldwide in 2016: An update, World J Gastroenterol, 23, 3632, 10.3748/wjg.v23.i20.3632 Pfaffl, 2001, A new mathematical model for relative quantification in real-time RT-PCR, Nucleic Acids Res, 29, 10.1093/nar/29.9.e45 Kralik, 2017, A basic guide to real time PCR in microbial diagnostics: Definitions, parameters, and everything, Front Microbiol, 8, 1, 10.3389/fmicb.2017.00108 Bustin, 2009, The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments, Clin Chem, 55, 611, 10.1373/clinchem.2008.112797 Schmittgen, 2008, Analyzing real-time PCR data by the comparative CT method, Nat Protoc, 3, 1101, 10.1038/nprot.2008.73 Byron, 2016, Translating RNA sequencing into clinical diagnostics: Opportunities and challenges, Nat Rev Genet, 17, 257, 10.1038/nrg.2016.10 Amitay, 2019, Factors associated with false-positive fecal immunochemical tests in a large German colorectal cancer screening study, Int J Cancer, 144, 2419, 10.1002/ijc.31972